NTOX-09. RECOMMENDED PHASE II DOSE OF INTRA-ARTERIAL MELPHALAN GIVEN WITH INTRA-ARTERIAL CARBOPLATIN, OSMOTIC BLOOD-BRAIN BARRIER DISRUPTION AND DELAYED OTOPROTECTIVE SODIUM THIOSULFATE FOR PATIENTS WITH RECURRENT OR PROGRESSIVE CNS EMBRYONAL OR GERM CELL TUMORS
Prakash Ambady(Legacy Health), Edward A. Neuwelt(Oregon Health & Science University), Jenny Firkins(Oregon Health & Science University), Amy Huddleston(Oregon Health & Science University), João Prola Netto, Kirsten Johansson(Oregon Health & Science University), Dominic A. Siler(University of Wisconsin–Madison), Rongwei Fu(Oregon Health & Science University), Jessica James(Oregon Health & Science University), Nancy D. Doolittle(Oregon Health & Science University)
Cited by 0
Related Papers
Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits
|Proceedings of the National Academy of Sciences|2007|784
Engaging neuroscience to advance translational research in brain barrier biology
|Nature reviews. Neuroscience|2011|586
Potassium Modulates Electrolyte Balance and Blood Pressure through Effects on Distal Cell Voltage and Chloride
|Cell Metabolism|2015|455
Chemotherapy Delivery Issues in Central Nervous System Malignancy: A Reality Check
|Journal of Clinical Oncology|2007|414